83578 Federal Register / Vol. 88, No. 229 / Thursday, November 30, 2023 / Notices 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 29, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 29, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on October 23, 2023, 

Pharmaron Manufacturing Services (US) 

LLC, 498 Washington Street, Coventry, 

Rhode Island 02816, applied to be 

registered as a bulk manufacturer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Dimethyltryptamine ........ 7435 I 

The company plans to bulk 

manufacture the listed controlled 

substance for the purpose of producing 

material for clinical trials. No other 

activities for this drug code are 

authorized for this registration. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–26343 Filed 11–29–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–1298] 

Importer of Controlled Substances 

Application: Pharmaron Manufacturing 

Services (US) LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Pharmaron Manufacturing 

Services (US) LLC has applied to be 

registered as an importer of basic 

class(es) of controlled substance(s). 

Refer to SUPPLEMENTARY INFORMATION

listed below for further drug 

information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may submit 

electronic comments on or objections to 

the issuance of the proposed registration 

on or before January 2, 2024. Such 

persons may also file a written request 

for a hearing on the application on or 

before January 2, 2024. 

ADDRESSES: The Drug Enforcement 

Administration requires that all 

comments be submitted electronically 

through the Federal eRulemaking Portal, 

which provides the ability to type short 

comments directly into the comment 

field on the web page or attach a file for 

lengthier comments. Please go to 

https://www.regulations.gov and follow 

the online instructions at that site for 

submitting comments. Upon submission 

of your comment, you will receive a 

Comment Tracking Number. Please be 

aware that submitted comments are not 

instantaneously available for public 

view on https://www.regulations.gov. If 

you have received a Comment Tracking 

Number, your comment has been 

successfully submitted and there is no 

need to resubmit the same comment. All 

requests for a hearing must be sent to: 

(1) Drug Enforcement Administration, 

Attn: Hearing Clerk/OALJ, 8701 

Morrissette Drive, Springfield, Virginia 

22152; and (2) Drug Enforcement 

Administration, Attn: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing should 

also be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on October 30, 2023, 

Pharmaron Manufacturing Services (US) 

LLC, 498 Washington Street, Conventry, 

Rhode Island 02816, applied to be 

registered as an importer of the 

following basic class(es) of controlled 

substance(s): 

Controlled substance Drug 

code Schedule 

Dimethyltryptamine .......... 7435 I 

The company purpose of importing 

Dimethyltryptamine (7435) is to 

conduct process and analytical 

technology transfer, further process, and 

analytical development as needed and 

subsequently manufacture/produce an 

Active Pharmaceutical Ingredient under 

Good Manufacturing Practices at the US 

Pharmaron site (Pharmaron 

Manufacturing Services (US) LLC in 

Coventry, Rhode Island. No other 

activity for this drug code is authorized 

for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Claude Redd, 

Acting Deputy Assistant Administrator. 

[FR Doc. 2023–26342 Filed 11–29–23; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

[OMB Number 1110–0057] 

Agency Information Collection 

Activities; Proposed eCollection 

eComments Requested; Uniform Crime 

Reporting (UCR) Instrument Pretesting 

and Burden Estimation Generic 

Clearance 

AGENCY: Federal Bureau of 

Investigation, Department of Justice. 

ACTION: 30-Day notice. 

SUMMARY: The Federal Bureau of 

Investigation (FBI), Department of 

Justice (DOJ), will be submitting the 

following information collection request 

to the Office of Management and Budget 

(OMB) for review and approval in 

accordance with the Paperwork 

Reduction Act of 1995. The proposed 

information collection was previously 

published in the Federal Register on 

September 15, 2023, allowing a 60-day 

comment period. 

DATES: Comments are encouraged and 

will be accepted for 30 days until 

January 2, 2024. 

FOR FURTHER INFORMATION CONTACT: If 

you have comments especially on the 

estimated public burden or associated 

response time, suggestions, or need a 

copy of the proposed information 

collection instrument with instructions 

or additional information, please 

contact: Edward L. Abraham, Crime and 

Law Enforcement Statistics Unit Chief, 

FBI, CJIS Division, Module D–1, 1000 

Custer Hollow Road, Clarksburg, West 

Virginia 26306; telephone number: 304– 

625–4830, email: elabraham@fbi.gov. 

SUPPLEMENTARY INFORMATION: Written 

comments and suggestions from the 


khammond on DSKJM1Z7X2PROD with NOTICES

I I 

I I